1. Home
  2. AAON vs ERAS Comparison

AAON vs ERAS Comparison

Compare AAON & ERAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AAON Inc.

AAON

AAON Inc.

HOLD

Current Price

$75.52

Market Cap

6.1B

Sector

Industrials

ML Signal

HOLD

Logo Erasca Inc.

ERAS

Erasca Inc.

HOLD

Current Price

$14.54

Market Cap

6.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AAON
ERAS
Founded
1988
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.1B
6.3B
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
AAON
ERAS
Price
$75.52
$14.54
Analyst Decision
Buy
Buy
Analyst Count
6
9
Target Price
★ $134.75
$24.11
AVG Volume (30 Days)
1.0M
★ 4.9M
Earning Date
11-05-2026
11-11-2026
Dividend Yield
★ 0.54%
N/A
EPS Growth
N/A
★ 36.23
EPS
★ 1.15
N/A
Revenue
★ $1,442,076,000.00
N/A
Revenue This Year
$60.43
N/A
Revenue Next Year
$18.59
N/A
P/E Ratio
$64.48
★ N/A
Revenue Growth
★ 20.11
N/A
52 Week Low
$71.91
$2.11
52 Week High
$150.46
$24.28

Technical Indicators

Market Signals
Indicator
AAON
ERAS
Relative Strength Index (RSI) 39.04 46.18
Support Level N/A $13.56
Resistance Level $89.67 $15.03
Average True Range (ATR) 3.68 1.02
MACD -1.22 0.04
Stochastic Oscillator 18.59 45.32

Price Performance

Historical Comparison
AAON
ERAS

About AAON AAON Inc.

AAON Inc is a manufacturer of air-conditioning and heating equipment. The products include rooftop units, chillers, packaged outdoor mechanical rooms, air-handling units, makeup air units, energy-recovery units, condensing units, geothermal heat pumps, and self-contained units and coils. The company operates through three segments: AAON Oklahoma, AAON Coil Products, and BASX. It generates the majority of its revenue from the AAON Oklahoma segment which derives maximum revenue, engineers, manufactures, and sells, semi-custom, and custom HVAC systems, designs and manufactures control solutions, and sells retail parts to customers through retail part stores and online.

About ERAS Erasca Inc.

Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Its focused RAS/MAPK pathway pipeline comprises modality-agnostic programs aligned with three therapeutic strategies of: targeting key upstream and downstream signaling nodes in the RAS/MAPK pathway; targeting RAS directly; and targeting escape routes that emerge in response to treatment. Its pipeline includes two clinical-stage programs (ERAS-0015, a pan-RAS molecular glue; and ERAS-4001, a pan-KRAS inhibitor), and ERAS-12, a discovery-stage program.

Share on Social Networks: